Leukine (Sargramostim) for Parkinson's Disease

This study has been completed.
Sponsor:
Collaborators:
Sanofi
National Institute of Neurological Disorders and Stroke (NINDS)
UNeMed
Nebraska Neuroscience Alliance
Information provided by (Responsible Party):
Howard Gendelman, MD, University of Nebraska Medical Center
ClinicalTrials.gov Identifier:
NCT01882010
First received: June 13, 2013
Last updated: May 20, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2016
  Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)